Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma

  • STATUS
    Recruiting
  • participants needed
    20
  • sponsor
    Rochester General Hospital
Updated on 5 March 2021
platelet count
metastases
cancer
lymphoma
measurable disease
karnofsky performance status
neutrophil count
cancer therapy
t-cell lymphoma
renal function test
cutaneous t-cell lymphoma
pet scans
metastatic tumor

Summary

This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.

Description

The aim of this study is to evaluate the efficacy of doxycycline in relapsed Cutaneous T-cell Lymphomas (CTCL). The primary objective is to determine the overall response rate of doxycycline monotherapy in patients with relapsed CTCL.

Details
Condition Mycosis Fungoides, Sezary Syndrome, cutaneous T-cell lymphoma, Lymphoproliferative Disorder, T-Cell Lymphoma, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Lymphoproliferative disorders, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome, Sézary Syndrome
Treatment Doxycycline monohydrate, Doxycycline monohydrate
Clinical Study IdentifierNCT02341209
SponsorRochester General Hospital
Last Modified on5 March 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note